Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026)
Cogent Biosciences (COGT) posted quarterly Interest Coverage Ratio of 15.18 for Q1 2026, up 99.92% year-over-year from 7.59 in Q1 2025, and up 80.75% quarter-over-quarter from 78.84 in Q4 2025.
Analysis
Cogent Biosciences (COGT) Interest Coverage Ratio (2025 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Interest Coverage Ratio for 10 consecutive years, with 15.18 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 99.92% year-over-year to 15.18; the TTM figure through Mar 2026 stood at 53.03 (up 99.93% YoY), while the FY2025 annual figure was 0.45, up 64.66% from the prior year.
- Interest Coverage Ratio advanced to 15.18 in Q1 2026 per COGT's latest filing, from 78.84 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.92 in Q2 2022 and bottomed at 18733.25 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 1426.33 across 5 years, with a median of 78.84 in 2025.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 48721.25% — and 2026, when it soared 99.92%.
- Cogent Biosciences' Interest Coverage Ratio stood at 111.88 in 2022, then soared by 56.04% to 49.18 in 2023, then soared by 59.07% to 20.13 in 2024, then tumbled by 291.65% to 78.84 in 2025, then surged by 80.75% to 15.18 in 2026.
- Business Quant data shows COGT's Interest Coverage Ratio at 15.18 in Q1 2026, 78.84 in Q4 2025, and 14.5 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Cogent Biosciences | 5.94 Bn | 5.94 Bn | - | -84.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -84.34 |
| Mar 31, 2026 | -85.41 |
| Dec 31, 2025 | -77.19 |
| Sep 30, 2025 | -57.13 |
| Jun 30, 2025 | -240.71 |